The truth about the drug companies: how they deceive us and what to do about it
Angell watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
New York
Random House
2004
|
| Ausgabe: | 1st ed. |
| Schlagworte: | |
| Zusammenfassung: | Angell watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled and increasingly failed to meet spiraling prescription drug prices. |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | XX, 305 p. Ill. |
| ISBN: | 0375508465 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV019653721 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 050111s2004 xxua||| |||| 00||| eng d | ||
| 010 | |a 2004041212 | ||
| 020 | |a 0375508465 |c cloth : alk. paper |9 0-375-50846-5 | ||
| 035 | |a (OCoLC)54035188 | ||
| 035 | |a (DE-599)BVBBV019653721 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-20 |a DE-M382 |a DE-578 | ||
| 050 | 0 | |a HD9666.5 | |
| 082 | 0 | |a 338.4/36151/0973 |2 22 | |
| 082 | 0 | |a 338.4361510973 | |
| 084 | |a QV 736 |2 nlm | ||
| 100 | 1 | |a Angell, Marcia |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a The truth about the drug companies |b how they deceive us and what to do about it |c Marcia Angell |
| 250 | |a 1st ed. | ||
| 264 | 1 | |a New York |b Random House |c 2004 | |
| 300 | |a XX, 305 p. |b Ill. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 520 | 3 | |a Angell watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled and increasingly failed to meet spiraling prescription drug prices. | |
| 650 | 7 | |a Ethiek |2 gtt | |
| 650 | 7 | |a Farmaceutische industrie |2 gtt | |
| 650 | 4 | |a Industrie pharmaceutique - États-Unis - Coût | |
| 650 | 4 | |a Médicaments - Politique gouvernementale - États-Unis | |
| 650 | 4 | |a Médicaments - Prix - États-Unis | |
| 650 | 4 | |a Médicaments - Publicité - États-Unis | |
| 650 | 4 | |a Médicaments - Recherche - États-Unis - Finances | |
| 650 | 7 | |a Winst |2 gtt | |
| 650 | 4 | |a Ethik | |
| 650 | 4 | |a Pharmaceutical industry |z United States |x Costs | |
| 650 | 4 | |a Drugs |x Prices |z United States | |
| 650 | 4 | |a Drugs |x Research |z United States |x Finance | |
| 650 | 4 | |a Prescription pricing |z United States | |
| 650 | 4 | |a Advertising |x Drugs |z United States | |
| 650 | 4 | |a Pharmaceutical policy |z United States | |
| 651 | 4 | |a USA | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-012982304 | ||
Datensatz im Suchindex
| _version_ | 1804133030310182912 |
|---|---|
| any_adam_object | |
| author | Angell, Marcia |
| author_facet | Angell, Marcia |
| author_role | aut |
| author_sort | Angell, Marcia |
| author_variant | m a ma |
| building | Verbundindex |
| bvnumber | BV019653721 |
| callnumber-first | H - Social Science |
| callnumber-label | HD9666 |
| callnumber-raw | HD9666.5 |
| callnumber-search | HD9666.5 |
| callnumber-sort | HD 49666.5 |
| callnumber-subject | HD - Industries, Land Use, Labor |
| ctrlnum | (OCoLC)54035188 (DE-599)BVBBV019653721 |
| dewey-full | 338.4/36151/0973 338.4361510973 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/36151/0973 338.4361510973 |
| dewey-search | 338.4/36151/0973 338.4361510973 |
| dewey-sort | 3338.4 536151 3973 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| edition | 1st ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02275nam a2200553zc 4500</leader><controlfield tag="001">BV019653721</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">050111s2004 xxua||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2004041212</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0375508465</subfield><subfield code="c">cloth : alk. paper</subfield><subfield code="9">0-375-50846-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)54035188</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV019653721</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-20</subfield><subfield code="a">DE-M382</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9666.5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/36151/0973</subfield><subfield code="2">22</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4361510973</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QV 736</subfield><subfield code="2">nlm</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Angell, Marcia</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The truth about the drug companies</subfield><subfield code="b">how they deceive us and what to do about it</subfield><subfield code="c">Marcia Angell</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Random House</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XX, 305 p.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">Angell watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled and increasingly failed to meet spiraling prescription drug prices.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ethiek</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Farmaceutische industrie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique - États-Unis - Coût</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Politique gouvernementale - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Prix - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Publicité - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Recherche - États-Unis - Finances</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Winst</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ethik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="z">United States</subfield><subfield code="x">Costs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Prices</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="z">United States</subfield><subfield code="x">Finance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prescription pricing</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Advertising</subfield><subfield code="x">Drugs</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical policy</subfield><subfield code="z">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-012982304</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV019653721 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T20:02:14Z |
| institution | BVB |
| isbn | 0375508465 |
| language | English |
| lccn | 2004041212 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-012982304 |
| oclc_num | 54035188 |
| open_access_boolean | |
| owner | DE-20 DE-M382 DE-578 |
| owner_facet | DE-20 DE-M382 DE-578 |
| physical | XX, 305 p. Ill. |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | Random House |
| record_format | marc |
| spelling | Angell, Marcia Verfasser aut The truth about the drug companies how they deceive us and what to do about it Marcia Angell 1st ed. New York Random House 2004 XX, 305 p. Ill. txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references and index Angell watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled and increasingly failed to meet spiraling prescription drug prices. Ethiek gtt Farmaceutische industrie gtt Industrie pharmaceutique - États-Unis - Coût Médicaments - Politique gouvernementale - États-Unis Médicaments - Prix - États-Unis Médicaments - Publicité - États-Unis Médicaments - Recherche - États-Unis - Finances Winst gtt Ethik Pharmaceutical industry United States Costs Drugs Prices United States Drugs Research United States Finance Prescription pricing United States Advertising Drugs United States Pharmaceutical policy United States USA |
| spellingShingle | Angell, Marcia The truth about the drug companies how they deceive us and what to do about it Ethiek gtt Farmaceutische industrie gtt Industrie pharmaceutique - États-Unis - Coût Médicaments - Politique gouvernementale - États-Unis Médicaments - Prix - États-Unis Médicaments - Publicité - États-Unis Médicaments - Recherche - États-Unis - Finances Winst gtt Ethik Pharmaceutical industry United States Costs Drugs Prices United States Drugs Research United States Finance Prescription pricing United States Advertising Drugs United States Pharmaceutical policy United States |
| title | The truth about the drug companies how they deceive us and what to do about it |
| title_auth | The truth about the drug companies how they deceive us and what to do about it |
| title_exact_search | The truth about the drug companies how they deceive us and what to do about it |
| title_full | The truth about the drug companies how they deceive us and what to do about it Marcia Angell |
| title_fullStr | The truth about the drug companies how they deceive us and what to do about it Marcia Angell |
| title_full_unstemmed | The truth about the drug companies how they deceive us and what to do about it Marcia Angell |
| title_short | The truth about the drug companies |
| title_sort | the truth about the drug companies how they deceive us and what to do about it |
| title_sub | how they deceive us and what to do about it |
| topic | Ethiek gtt Farmaceutische industrie gtt Industrie pharmaceutique - États-Unis - Coût Médicaments - Politique gouvernementale - États-Unis Médicaments - Prix - États-Unis Médicaments - Publicité - États-Unis Médicaments - Recherche - États-Unis - Finances Winst gtt Ethik Pharmaceutical industry United States Costs Drugs Prices United States Drugs Research United States Finance Prescription pricing United States Advertising Drugs United States Pharmaceutical policy United States |
| topic_facet | Ethiek Farmaceutische industrie Industrie pharmaceutique - États-Unis - Coût Médicaments - Politique gouvernementale - États-Unis Médicaments - Prix - États-Unis Médicaments - Publicité - États-Unis Médicaments - Recherche - États-Unis - Finances Winst Ethik Pharmaceutical industry United States Costs Drugs Prices United States Drugs Research United States Finance Prescription pricing United States Advertising Drugs United States Pharmaceutical policy United States USA |
| work_keys_str_mv | AT angellmarcia thetruthaboutthedrugcompanieshowtheydeceiveusandwhattodoaboutit |